X0508 4 2024-08-27 0001682852 Moderna, Inc. MRNA 0001736359 Mock James M 325 BINNEY STREET CAMBRIDGE MA 02142 1 Chief Financial Officer 1 Common Stock 2024-08-27 4 M 0 1326 A 8595 D Common Stock 2024-08-27 4 M 0 1326 A 9921 D Common Stock 2024-08-28 4 S 0 1321 79.3949 D 8600 D Performance Stock Units 2024-08-27 4 M 0 1326 0 D Common Stock 1326 2652 D Restricted Stock Units 2024-08-27 4 M 0 1326 0 D Common Stock 1326 2652 D Performance stock units convert into common stock on a one-for-one basis. Restricted stock units convert into common stock on a one-for-one basis. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of performance stock units and restricted stock units. This "sell-to-cover" transaction was mandated by the Issuer's equity incentive plan and does not represent a discretionary trade by the reporting person. 25% of the shares subject to this performance stock unit award vested on May 31, 2024 upon determination of achievement of the performance criteria, with the remainder vesting in three (3) equal installments on August 27, 2024, November 27, 2024 and February 27, 2025. 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter. /s/ James Dillon, As Attorney-in-Fact 2024-08-29